Content about Neurology

July 5, 2010
Caraco launches generic dementia treatment

Generic drug maker Caraco Pharmaceutical Labs has begun shipping a drug for treating dementia, Caraco...

June 20, 2010
Valeant, Biovail to merge

U.S. drug maker Valeant and Canadian drug maker Biovail will merge, the two companies said...

June 15, 2010
FDA approves generic Lorazepam Intensol

The Food and Drug Administration has approved a generic drug for anxiety disorder made by...

June 14, 2010
UCB launches liquid Vimpat

An oral liquid version of an epilepsy drug made by UCB has become available, UCB...

June 3, 2010
Mylan’s generic shingles treatment approved by FDA

The Food and Drug Administration has approved Mylan’s version of a drug for complications related...

June 3, 2010
Report: 20% of high school students have abused prescription drugs

One-in-5 high school students have abused prescription drugs, according to a survey released Thursday by...

May 25, 2010
Mylan launches generic insomnia treatment

Mylan has launched a generic short-term treatment for insomnia, the generic drug maker said Tuesday....

May 3, 2010
Mylan gets regulatory approval for generic Zyban

The Food and Drug Administration has approved Mylan’s generic version of a smoking-cessation drug, Mylan...

March 30, 2010
Cobroxin to be featured on morning talk show

XenaCare announced Wednesday that its over-the-counter pain reliever, Cobroxin, will be featured on a segment...

March 24, 2010
FDA approves expanded use of Xifaxan

The Food and Drug Administration has approved a new use for a drug made by...

March 21, 2010
Shingles drug may capture half the market, Decision Resources predicts

A once-a-day formulation of a Pfizer drug potentially could capture half of the market for...

March 17, 2010
FDA approves anxiety disorder generic

The Food and Drug Administration has approved a generic anxiety drug made by Actavis, the...

March 10, 2010
Study finds Vimpat 'significantly' reduces partial-onset seizures

An investigational drug can reduce seizures in adolescents and adults with epilepsy when added on...

February 3, 2010
Labopharm's Oleptro approved by FDA

The Food and Drug Administration has approved a new drug for treating major depressive disorder...

January 26, 2010
EpiCept gets orphan drug designation from FDA

A topical treatment for post-herpetic neuralgia, more commonly known as shingles, has received an orphan...

January 25, 2010
Teva wins patent battle over Merck's Temodar

Teva Pharmaceutical Industries may soon get the green light to market a generic drug for...

January 18, 2010
Watson files application for Lidoderm generic

Watson Pharmaceuticals has filed for regulatory approval of a generic version of a pain drug...

January 3, 2010
FDA accepts NDA filing for retigabine

Valeant Pharmaceuticals announced that the Food and Drug Administration has accepted for review the new...

October 25, 2009
Report: PSE sales plummet in Washington, Mo., as Rx-only ordinance is enacted

A white donkey painted in black stripes does not a zebra make. In fact, all...

NEW YORK A white donkey painted in black stripes does not a zebra make. In fact, all you really have is a donkey and a whole lot of paint. Something similar could be said here, because a 92% reduction in PSE sales does not correlate with a 92% reduction in the number of meth addicts cruising the streets.

 

The fact is a 92% reduction in PSE sales doesn’t add up to much of anything positive.

 

 

September 13, 2009
Louisiana seeks to curb methamphetamine abuse with new legislation

California and Missouri legislatures may want to take a page out of Louisiana’s playbook in...

NEW YORK California and Missouri legislatures may want to take a page out of Louisiana’s playbook in the pursuit of curbing illicit methamphetamine production. Because here, everyone wins (unless, of course, you’re a meth addict).